Related references
Note: Only part of the references are listed.Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients
M. A. Vera-Recabarren et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Cutaneous lupus erythematosus: Update of therapeutic options
Annegret Kuhn et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Cutaneous lupus erythematosus: Update of therapeutic options
Annegret Kuhn et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Acute myocardial infarction in a patient with cutaneous lupus erythematosus treated with thalidomide
A. Llambrich et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2007)
Cutaneous lupus erythematosus: Understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies
Henry J. Lee et al.
AUTOIMMUNITY (2006)
Positive and negative effects of thalidomide on refractory cutaneous lupus erythematosus
C Briani et al.
AUTOIMMUNITY (2005)
The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): An outcome instrument for cutaneous lupus erythematosus
J Albrecht et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Management of 'refractory' skin disease in patients with lupus erythematosus
JP Callen
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2005)
Thalidomide: dermatological indications, mechanisms of action and side-effects
JJ Wu et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens
MJ Cuadrado et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients
A Coelho et al.
LUPUS (2005)
Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus
TS Housman et al.
ARCHIVES OF DERMATOLOGY (2003)
Thalidomide treatment leading thrombotic events: two cases
J Gachon et al.
REVUE DE MEDECINE INTERNE (2002)
Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy
M Zangari et al.
BLOOD (2001)
The cutaneous pathology of lupus erythematosus: a review
AN Crowson et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2001)
Clinical and immunologic parameters during thalidomide treatment of lupus erythematosus
M Walchner et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2000)
Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus
KP Kyriakis et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2000)
Share Paper
